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Abstract
Evidence suggests that dopamine (DA) is crucial for initiation and termination as well as
sustained execution of movement. For the present study, it was hypothesized that DA plays a
more important role in initiation and termination of movement than in its sustained production.
To test these hypotheses, rats were trained to walk on a treadmill in a continuous and
discontinuous (walk 30 secs/stop 15 seconds) fashion for one hour while striatal DA samples
were collected using In Vivo Microdialysis (IVMCD). We predicted larger increases during
discontinuous compared to continuous walking. It was found that brain dialysate levels of DA
consistently increased from baseline to walking [p<0.05]. However, no significant difference was
found in brain dialysate DA between continuous and discontinuous walking [p>0.05]. Similar to
DA, its major metabolites DOPAC and HVA, and the serotonin metabolite 5-HIAA, increased
during treadmill walking from resting state levels [p<0.05]. None of these metabolites showed a
significant difference between continuous and discontinuous walking. The results of the present
study are important because they demonstrate that 1) increases in movement-related changes in
brain dialysate dopamine are detectable in contrast to many of the studies in the literature; and 2)
the converging changes in DA and its metabolites might be used to monitor changes in
functional utilization. In conclusion, a clear understanding for the modulatory role of DA in
movement production is crucial for the development of biomedical interventions involving basal
ganglia disease.
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Introduction
The Basal Ganglia Regulates Voluntary Movement
There are different motor systems that control movement in mammals. Activation of the
muscles needed for locomotion depends on four different primary motor systems: the descending
motor pathways, spinal motor circuits, cerebellum, and basal ganglia. Motor programs required
to activate the different muscles are located in the spinal cord but are controlled by cortical and
subcortical motor centers (Grillner et al., 2005; Duysens et al., 1998; Catsman-Berrevoets &
Kuypers, 1976; Dum & Strick, 1991; Kamiyama et al., 2015). Many studies have explored the
specific role each system plays in motor behavior. The descending motor pathways include
neuronal projections from the cortex or brain stem to the motor neurons of the spinal motor
circuits. These systems can regulate both reflexive and controlled movements. Interestingly, the
cerebellum and basal ganglia do not project directly to the motor circuits of the spinal cord,
which makes their role in motor regulation less intuitive. They are generally thought to have a
regulatory effect on motor behavior but their specific roles are still vague.
The cerebellum is believed to be involved in control of fine movement (Gao et al., 1996)
and the basal ganglia has been long associated with regulation of voluntary movement
(Middleton & Strick, 2000). Despite the number of studies dedicated to understanding the
function of the basal ganglia its specific role in movement regulation has remained elusive due to
the complexity of the circuitry. A study involving decorticate dogs, cats, and rats showed they
could still perform self-maintaining behaviors like eating, drinking, walking, running, and
mating almost as well as normal animals (Bjursten et al., 1976; Bard & Macht, 1958; Bazzet &
Penfield 1922; Bignall & Schramm, 1974). Decorticate animals had all of the neocortex removed
but every other brain structure remained intact, including the basal ganglia. However, decorticate
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animals could not make plans and execute sequences of movements to adapt to new situations.
Therefore it has been theorized that the basal ganglia aids with the selection process of the motor
systems needed to perform a desired behavior (Grillner et al., 2005; Jueptner & Weiller, 1998)
rather than regulating the motivational intention behind them. Furthermore, pathologies
emerging from the disruption of the basal ganglia circuitry lead to a spectrum of motor problems
ranging from hyperkinesia (Hungtington’s disease) to hypokinesia (Parkinson’s disease), and
even cognitive deficits (Middleton & Strick, 2000; DeLong, 1990; Groves, 1983).
Reviews on basal ganglia function have speculated that this circuitry generally
contributes to the planning and execution of voluntary movements via a series of parallel loops
(DeLong, 1990). However, more recent interpretations have challenged the idea that the basal
ganglia controls movement in general (Middleton & Strick, 2000) and may instead play a role to
mediate more specific qualities of movement such as initiation and termination of movement
(Aceves et al., 2011; Grillner et al., 2005; DeLong, 1990), or goal-directed tasks (Takakusaki et
al., 2004). Recent studies on the neurobiology and neurochemistry of the basal ganglia also
support the idea that the basal ganglia plays a more specific role in modulation of initiation and
termination of voluntary movements via the
direct and indirect loops (Takakusaki et al.,
2004; Grillner et al., 2005; Aceves et al.,
2011).
Anatomy of the Basal Ganglia Circuitry
The basic organization of the basal
ganglia circuit is shown in Figure 1. Distinct

Figure 1. Basal Ganglia Circuit

areas of the cortex send excitatory glutamatergic projections to the striatum (Berendse et al.,
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1992; Donoghue & Herkenham, 1986; Künzle, 1975; Gerfen, 1984; Oka, 1980; Parthasarathy et
al., 1992; Ragsdale & Graybiel, 1990). The striatum is also referred as the “input” nucleus of the
circuit and it sends gamma-Aminobutyric acid (GABA) projections to the output nuclei. The
output nuclei include the internal portion of the Globus Pallidus (GPi) and the Substantia Nigra
pars Reticulata (SNr). The output nuclei in turn project an inhibitory GABAergic signal to the
thalamus. The thalamus then sends an excitatory signal back to the cortex, thus completing the
loop (Alexander & Crutcher, 1990).
The basal ganglia circuitry is composed of a direct and indirect pathway that have
opposite effects on cortical activation. The direct pathway sends projections directly from the
striatum to the output nuclei to ultimately disinhibit the thalamus and increase excitation of the
cortex. The indirect pathway, on the other hand, sends projections from the striatum to the
external portion of the globus pallidus (GPe) and the subthalamic nucleus (STN) before reaching
the output nuclei. This pathway increases the inhibitory input on thalamus, which ultimately
results in reduced excitation of the cortex (DeLong, 1990).
Initially the basal ganglia was solely described as a motor loop receiving input from
motor and pre-motor cortex. Later studies showed that virtually all areas of cortex, including
sensory and association cortices, also provided input to the basal ganglia circuitry (see Alexander
et al., 1986 for review) and that each cortical area projects to discrete corresponding areas of the
striatum (Gerfen, 1984; Künzle, 1975; Berendse 1992; Donoghue & Herkenham, 1986). For
example, association cortex projects to the associative striatal territory (Parent, 1990). This
evidence adds a new level of complexity to the understanding of this circuitry as it suggests that
there are multiple parallel basal ganglia loops. The different basal ganglia loops have been
subdivided into three main categories based on their function: motor, associative, and limbic.
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More recent views on the nature and role of parallel basal ganglia loops propose that although
the loops are activated independently they can function in an integrative way (Koob, 2009).
Interestingly, regardless of the nature of the function being modulated, all basal ganglia (corticostriatal) loops comprise the previously described direct and indirect pathways.
Multiple studies have speculated that activation of the motor basal ganglia direct and
indirect pathways modulates seemingly opposite behaviors such as initiation and termination of
movement (Aceves et al., 2011; Grillner et al., 2005; DeLong, 1990). The idea that the direct and
indirect pathways modulate opposite behaviors has also been proposed for similar parallel loops
that regulate drug addiction behaviors such as sensitization and resiliency to psychostimulants
(Ferguson et al., 2011; Ferguson et al., 2013).
Dopamine Selectively Activates the Direct and Indirect Pathways
A compelling observation is that dopaminergic input from the substantia nigra to the
striatum can selectively excite or inhibit the direct and indirect pathways respectively. The
striatum is mostly comprised of medium spiny neurons (MSNs) that express the two main DA
receptor subtypes: DR1 and DR2. DR1-expressing MSNs constitute the striato-nigral or direct
pathway, and DR2-expressing MSNs comprise the striato-pallidal or indirect pathway (Gerfen et
al., 1990). DA is believed to function as a comparator that regulates the excitatory and inhibitory
input from the basal ganglia circuitry by modulating the activation of each pathway (Groves,
1983). Disruption of the dopaminergic input from substantia nigra to striatum due to neuronal
death is the underlying neuropathology for the motor symptoms observed in Parkinson’s disease,
including problems initiating movement (DeLong, 1990). Dopamine’s ability to selectively
regulate the direct and indirect pathways makes it a viable candidate to control initiation and
termination of movement mediated by the basal ganglia.
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Inconsistent Reports of Dopamine Release in the Striatum During Continuous Locomotion in
Rats
It is assumed that DA is correlated with motor behavior, therefore many studies that
explore dopamine activity within the basal ganglia have used continuous locomotion as a tool to
evoke DA release. However increases in functional DA release are not always observed when
solely using continuous locomotion as a manipulation. Therefore, most studies have to rely on a
combination of locomotor behavior and pharmacological manipulations to elicit detectable
changes in DA activity.

Six studies that report changes in DA release during continuous

locomotion are inconsistent with each other (see Table 1). Two of these studies used treadmill
walking and four studies used the Rotarod test as a locomotor task during microdialysis testing to
measure striatal DA activity. Out of the six studies, two studies report significant increases in
DA release relative to baseline, two studies do not report the statistical results for DA release,
and two studies reported no significant increases in DA release.
Table 1. Increases in DA release in rats during continuous locomotion measured by microdialysis.

Article

Behavioral Design

DA Increase in Striatum

Castañeda et al., 1990

Treadmill Walking

Not significant

Damsma et al., 1992

Rotating Wheel

Not significant

Andersson et al., 2006

Rotarod Test

Not reported

Andersson et al., 2010

Rotarod Test

Not reported

Hattori et al., 1994

Treadmill Walking

Significant*

Bergquist et al., 2003

Rotarod Test

Significant*

These studies provide inconclusive results on the relationship between striatal DA release
and locomotor activity. Some authors argue that DA within the striatum is important for
maintaining locomotion, and others speculate that DA plays a more specific role within
5

movement. For example, some components of motor execution proposed to be mediated by
striatal DA are: voluntary vs. reflexive movement, initiation vs. termination, and disengagement
vs. engagement. The objective of this study is to explore the role of DA within the basal ganglia
to regulate initiation and termination of movement. This theory is based on the role DA has in
modulating the direct and indirect pathways to ultimately excite or inhibit the motor cortex.
Hypothesis: DA within the Basal Ganglia is Important for Initiation/Termination of Behavior
Despite the well-established association of DA with movement, there is a lack of
understanding about the fundamental role of the basal ganglia to produce movement and how
DA modulates this circuitry. A number of theoretical models have explicitly conjectured that DA
plays a role in the initiation and termination of movement by modulating the direct and indirect
pathways of the basal ganglia but have not been empirically tested (Groves, 1983; Surmeier et
al., 2009; Wickens, 2009).
Yamamoto et al. (1982) indirectly attempted to answer this question by looking at striatal
catecholamine (dopamine) release in rats engaged in reinforced intermittent circling behavior. In
this study, circling behavior was reinforced by giving sugar water as a reward. Dopamine
neurons from the substantia nigra have been shown to fire in response to a reward or rewardassociated stimulus (Schultz, 1998). Therefore this natural reinforcer was likely a confound in
evaluating whether catecholamine increase was due to the reinforcing effects of sugar water, the
repeated initiation/termination of intermittent circling behavior, or the motor component of
circling behavior.
Later, Schallert and Hall (1988) explored more explicitly the role of dopamine in
engagement and disengagement from movement using a hemiparkinsonian model in rats.
Behavioral testing was conducted after a unilateral 6-hydroxydopamine (6-OHDA) lesion to look
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at motor, sensory and disengagement behavior. They designed an experiment to determine
whether rats disengaged from consummatory behavior in response to tactile stimulation. Normal
rats will immediately stop drinking to pay attention to the vibrissal stimulation
(“disengagement”). Rats with a hemiparkinsonian lesion did not disengage when the stimulus
was presented on the contralateral side of the lesion. When stimulation was presented on the
ipsilateral side of the lesion rats displayed normal disengagement. Interestingly, if rats were not
engaged in drinking water they responded normally to the tactile stimulus on either side. This
evidence suggests that inability of rats to disengage was not a simple sensorimotor deficit.
Disengagement behavior can be decomposed in three basic steps: 1) initiation of the primary
(i.e., first) behavior 2) termination of the primary behavior and, 3) initiation of a new behavior
(Posner et al., 1984). Based on the claim that DA is important for modulating disengagement,
each of these steps (or all of them) can potentially be modulated by dopamine as well. Hence,
there are two key limitations to this study: 1) the lack of DA measures collected concurrently
with disengagement behavior and 2) delineating DA’s contribution to each step of
disengagement.
Based on the current literature, in this study we specifically explore the role of DA within
the basal ganglia in modulating initiation and termination of a primary behavior. Our global
hypothesis is that dopamine’s ability to regulate the balance between excitatory and inhibitory
neostriatal outflow (Groves, 1983) modulates the basal ganglia to produce initiation and
termination of voluntary movement. Our working hypothesis is that DA release increases
during intermittent walking that requires repeated initiation and termination of movement
compared to continuous locomotion. To test this hypothesis this we measured DA release in
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vivo using microdialysis while rats walked in a continuous or discontinuous (repeated start/stop)
fashion on a treadmill.
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Methods
Subjects
A total of 9 Wistar rats (5 male and 4 female) were used for the study. Rats were housed in a
temperature-controlled environment on a reversed 12:12 h light/dark cycle. During microdialysis
testing rats were housed for up to four days in a designated behavioral testing room. Food and
water were available ad-lib throughout the course of the study, except during the brief (4 hours)
experimental procedures, when they were removed from their home cage. All rats weighed
between 340 and 430 g at the time of testing. All experimental procedures were done in
accordance with IACUC regulations and approval.
Overview of the Protocol

General Timeline for the Experiment:
Days: 5 to 15
days
5-Day
Treadmill
Training

1 day
Surgery: IVMCD
Probe
Into NeoSTR

1 to 2
days

2 days

Recovery
Period

IVMCD Test:
Continuous or
Discontinuous

Histology

Figure 2. General Timeline for the Experiment

Rats were trained to walk on a treadmill until they were able to maintain a continuous steady
pace for at least an hour. All rats were trained for a minimum of 5 days and a maximum of 15
days depending on individual performance. After rats met walking criteria (continuous walking
for at least 1 hour at a minimum velocity of 7 m/min) they underwent stereotaxic surgery to
implant a microdialysis probe unilaterally into the striatum. Rats recovered from surgery for one
to two days before in-vivo microdialysis (IVMCD) testing. IVCMD testing was conducted for
two consecutive days. Dialysate samples were collected using similar procedures across both
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days: first, during baseline (a minimum of three 20-minute samples with <10% variability
between each other); second, during treadmill walking for 1 hour (three 20-minute samples);
and, third, only during the second day of testing, after amphetamine administration (one 20minute sample). After testing was completed, rats were perfused using standard histological
procedures and their brains were prepared to verify probe placement.
Experimental Design and Groups
A repeated measures design was employed with two factors, sample number
(microdialysis sampling bins) and walking condition (continuous walking vs. discontinuous
walking). All rats were tested for two consecutive days: continuous and discontinuous, one day
they completed the continuous condition and on the other day the discontinuous. The order of the
2 conditions was counterbalanced across subjects to control for order effects.
Treadmill Training
On the first day of treadmill training, rats were handled for 5 minutes and then allowed to
freely explore the treadmill for 20 minutes without any belt movement. Rats were then placed in
individual lanes to initiate the training routine. Initial treadmill speed and duration was set at 5
m/min for 15 minutes for all rats. The speed on the treadmill and the duration of the training
sessions was gradually increased according to individual performance for the following training
days. Treadmill velocity during the training period never exceeded 15 m/min for any animal.
Rats that met walking criteria (continuous walking for at least 1 hour at a minimum velocity of 7
m/min) before day 15 of training underwent stereotaxic surgery for microdialysis probe implant.
A total of 9 rats that did not meet criteria after training day 15 were culled from the experiment.
2 rats successfully completed microdialysis testing but were removed from the overall data
analysis due to incorrect probe placement at the ventricle, which resulted in null increases in

10

dopamine after a systemic injection of amphetamine given as a positive control for valid
detection of extracellular DA.
Surgical Procedures - Dialysis Probe Implant
Within 3 days from the last training session, rats underwent stereotaxic surgery for
unilateral microdialysis probe implant. Rats were anesthetized using the inhalational anesthetic
Isoflurane. Using standard stereotaxic procedures (Castañeda et al., 1990), the microdialysis
probe was implanted into the neostriatum in either the left or right hemisphere at the following
coordinates: A + 0.5 mm, L +/-2.5 and V 7.0 mm from bregma (Paxinos & Watson, 1986). The
animals were then placed into the test chamber and left overnight to recover for one or two days.
Based on previous experience in our laboratory on time needed for rats to recover from surgery,
we allowed rats that weighted less than 450g to recover for one day, and rats that weighed over
450 g to recover for two days. Ringers solution was pumped through the probe at 0.15 µl/min
during this time. Testing began after the surgery recovery period; at least 18 h after probe
implantation.
Construction of the Dialysis Probes and In Vitro Probe Recovery
Microdialysis probes with a 4 mm effective dialyzing length were built in accordance to
Castañeda et al. (1989). In vitro testing prior to surgery was conducted to determine recovery
values for DA, the DA metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic
acid (HVA), and the serotonin major metabolite 5-hydroxyindoleacetic acid (5-HIAA). Average
recovery percentage for DA was 29.16 ± 0.78 , DOPAC 26.61 ± 1.47 , HVA 24.32 ± 0.76 , and
5-HIAA 24.66 ± 0.68.
In Vivo Microdialysis Procedures

11

During testing, pump speed was set at 1.5 μl/min 30 minutes prior to initiating baseline
collections. A minimum of three consecutive 20-minute baseline samples that varied <10% from
each other were collected. Samples were stored on ice for short periods, but all were assayed
within 30 min of collection. After a stable baseline was collected, the animals were placed onto
the conveyor belt where they walked for 1 h (continuously or discontinuously). Treadmill
walking was defined as maintaining a steady but comfortable pace on the treadmill for a period
of one hour. Rats walked uninterrupted during the continuous condition; during discontinuous
walking rats walked for 30 sec with 15 sec rest intervals repeatedly throughout the one-hour
phase. Time intervals for discontinuous walking were selected in an effort to optimize the
repetitive pattern of initiating and terminating locomotion without disrupting overall walking
behavior, which we found to be the case with shorter walk times in early phases of this study.
During treadmill walking, three more 20-min samples were collected. At the end of testing day 1,
animals were placed in the same holding environment and left there overnight. The same
procedure from day 1 was repeated on the second testing using the other walking condition. At
the end of the second test day, animals were returned to the holding boxes where they received
an IP injection of 1.5 mg/kg of amphetamine (AMPH) to produce pharmacologically evoked DA
overflow. Thus, one more 20-minute sample was collected after the AMPH injection as a
positive control for working conditions of the animal preparation.
High Pressure Liquid Chromatography Coupled with Electrochemical Detection HPLC/EC
Reverse Phase Chromatography
HPLC methodology consists of two features for analysis, separation and detection, which
are used to assay for brain DA and its major metabolites. A volume of 10-20 µl Dialysate was
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injected into an HPLC system via a Rheodyne Model 7125 manual injector. The mobile-phase
was optimized for DA detection.
Electrochemical Detection
A High Sensitivity Analytical Cell (ESA Model 5100A Coulochem Detector with a
Model 5011 Analytical Cell) was used with the first electrode set to oxidize at +340 mV (500 nA
sensitivity) and the second electrode was set to reduce at -340 mV (5 nA sensitivity). A
Coulochem II detector (Model 5200A) was used to estimate unknown concentrations of analytes
based on previously injected standards using linear regression analysis. The chromatographs
were quantified using EZChrom SI software (Agilent Technologies).
Intracardial Perfusion and Histology
Within one week from the end of the experiment rats underwent standard intracardial
perfusion to prepare the brain for histology and staining. After perfusion, 30 µm thick coronal
slices of the brain were obtained 1 mm rostral and caudal of the implantation site. Brain slices
were stained using cresyl violet and examined for accurate placement of the microdialysis probe
with a projecting microscope. Figure 3 shows the placement of
microdialysis probes in 7 out of the 9 animals that participated in
the study. The two brains not shown were lost due to technical
difficulties before brains could be harvested for histological
examination.
Data Analysis
Figure 3. Histological analyses revealed
that microdialysis probes were implanted
within the striatum for six of the animals
in which histology was conducted.

Differences in baseline levels across conditions

were

explored using a two-way repeated measures ANOVA with two

within-subjects factors: walking condition and baseline sample number. Second, a two-way
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ANOVA with two within-subject factors: walking condition and DA sample during treadmill
walking (mean baseline, 20-min, 40-min, 60-min) was conducted to assess changes in
extracellular DA levels from baseline to treadmill walking. Post-hoc analyses were conducted
using Sidak-Bonferroni test. The same statistical procedures were used to assess differences in
baseline levels and changes during treadmill walking for the DA metabolites DOPAC and HVA,
as well as the serotonin metabolite 5-HIAA.
A paired-samples t-test was conducted to analyze DA levels as a function of active
walking time by comparing dialysate levels of DA based on the absolute time rats spent walking
in both conditions. To test this, the average was calculated for the three samples collected during
treadmill running for both the continuous and discontinuous test phases. Next, two thirds of the
DA levels in the continuous condition were calculated to predict proportionate levels of 40
minutes of active walking, the time spent walking in the discontinuous phase. A paired-samples
t-test was conducted to compare extracellular DA levels during active walking in the
Discontinuous phase versus 60% of that calculated from the Continuous condition.
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Results
Extracellular Dopamine Levels During Continuous and Discontinuous Treadmill Walking.
Figure 3 illustrates extracellular DA estimated by microdialysis during baseline and
treadmill walking. First, the three baseline samples of DA collected just before the two
conditions of treadmill walking were compared. There were no significant differences in basal
levels between continuous and discontinuous walking [F(1,8)=0.007; p=ns]. There was a
significant main effect of repeated sampling across the three 20-min dialysate samples collected
during baseline [F(2,16)=4.208; p<0.05]; but pairwise post-hoc analyses across time points
revealed no significant differences. There was no interaction across baseline sampling and
walking condition [F(2,16)=0.5222; p=ns].Therefore, all three baseline samples were collapsed
into a baseline average for continuous (21.05 ± 3.31 fmol/min) and discontinuous (20.80 ± 2.59
fmol/min) walking for use in subsequent analyses comparing baseline levels of extracellular DA
against samples taken during walking.
A repeated measures two-way ANOVA was used to analyze the effects of treadmill
walking on DA levels. No significant differences in extracellular DA were found between
continuous vs. discontinuous treadmill walking [F(1,8)=0.001; p=ns]. A main effect over time
was found for DA [F(3,24)=21.15; p<0.001]. Subsequent post-hoc analyses revealed significant
differences from baseline vs. 20-, 40- and 60-min (p<0.05). The interaction between walking
condition and repeated measures of extracellular DA was not significant [F(3,24)=0.606; p=ns].
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Figure 4. Extracellular DA levels during baseline and both treadmill walking conditions. There was a significant increase
in extracellular DA across all samples collected during treadmill walking compared to the mean (±SEM) of baseline
(p<0.05).
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separate t-test was conducted taking into account the overall walking time of each phase. While
the total testing period was the same across both conditions (60 minutes), the total active
walking time during continuous walking was 60 minutes but only 40 minutes during
discontinuous walking. Therefore Figure 5 illustrates extracellular DA levels during
discontinuous compared to two thirds of the continuous condition. There was a significant
difference in the scores for discontinuous (M=26.550, SD=9.020) and continuous (M=17.358,
SD=7.627) conditions; paired t(8)=3.289, p < 0.05.
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DA During Active Running
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Fmol/min

30
20
10
0

2/3 Continuous

Discontinuous

Figure 5. DA during active treadmill walking. When dialysate levels of DA were adjusted in the Continuous condition to
factor out differences in the amount of walking compared to the Discontinuous condition, there was a significantly higher
amount of DA overflow when repetitive initiation and termination of walking was present. (p<0.05)	
  

Extracellular DOPAC Levels During Continuous and Discontinuous Treadmill Walking.
Figure 4 illustrates extracellular DOPAC estimated by microdialysis during baseline and
treadmill walking. First, the three baseline samples of DOPAC collected just before the two
conditions of treadmill walking were compared. There were no significant differences in basal
levels between continuous and discontinuous walking [F(1,8)=0.009; p=ns]. No significant
differences were found within repeated sampling across the three 20-min dialysate samples
collected during baseline [F(2,16)=0.087; p=ns].There was no interaction across baseline
sampling and walking condition [F(2,16)=1.184; p=ns].Therefore, all three baseline samples
were collapsed into a baseline average for continuous (3984.97 ± 504.39 fmol/min) and
discontinuous (4203.89 ± 511.53 fmol/min) walking for use in subsequent analyses comparing
baseline levels of extracellular DA against samples taken during walking.
A repeated measures two-way ANOVA was used to analyze the effects of treadmill
walking on DOPAC levels. No significant differences in extracellular DOPAC were found
between continuous vs. discontinuous treadmill walking [F(1,8)=0.027; p=ns]. A main effect
17

over time was found for DOPAC [F(3,24)=31.83; p<0.001]. Subsequent post-hoc analyses
revealed significant differences from baseline vs. 20-, 40- and 60-min (p<0.05). The interaction
between walking condition and repeated measures of DOPAC was not significant
[F(3,24)=1.060; p=ns].
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Figure 6. Extracellular DOPAC levels during baseline and both treadmill walking conditions. There was a significant
increase in extracellular DOPAC across all samples collected during treadmill walking compared to the mean (±SEM) of
baseline (p<0.05).
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Figure 5 illustrates extracellular HVA estimated by microdialysis during baseline and
W

W

W

treadmill walking. First, the three baseline samples of HVA collected just before the two
conditions of treadmill walking were compared. There were no significant differences in basal
levels between continuous and discontinuous walking [F(1,9)=0.209; p=ns]. No significant
differences were found within repeated sampling across the three 20-min dialysate samples
collected during baseline [F(2,16)=0.924; p=ns]. There was no interaction across baseline
sampling and walking condition [F(2,16)=1.213; p=ns]. Therefore, all three baseline samples
were collapsed into a baseline average for continuous (3197.43 ± 606.10 fmol/min) and
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discontinuous (3665.95 ± 798.13 fmol/min) walking for use in subsequent analyses comparing
baseline levels of extracellular DA against samples taken during walking.
A repeated measures two-way ANOVA was used to analyze the effects of treadmill
walking on HVA levels. No significant differences in extracellular HVA were found between
continuous vs. discontinuous treadmill walking [F(1,8)=0.243; p=ns]. A main effect over time
was found for HVA [F(3,24)=23.58; p<0.001]. During discontinuous walking, subsequent posthoc analysis revealed that significant differences from baseline vs. 20-min, 40-min and 60-min
(p<0.05). During continuous walking, post-hoc analysis revealed significant differences between
baseline vs. 40-min, 60-min during continuous walking (p<0.05). The interaction between
walking condition and repeated measures of HVA was not significant [F(3,24)=0.335; p=ns].
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Figure 7. Extracellular HVA levels during baseline and both treadmill walking conditions. There was a significant
increase in extracellular HVA across during the 40- and 60-min samples collected during treadmill walking for both
conditions compared to the mean (±SEM) of baseline (p<0.05).
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Figure 6 illustrates extracellular 5-HIAA estimated by microdialysis during baseline and
treadmill walking. First, the three baseline samples of 5-HIAA collected just before the two
conditions of treadmill walking were compared. There were no significant differences in basal
levels between continuous and discontinuous walking [F(1,8)=0.492; p=ns]. No significant
differences were found within repeated sampling across the three 20-min dialysate samples
collected during baseline [F(2,16)=0.069; p=ns]. There was no interaction across baseline
sampling and walking condition [F(2,16)=3.425; p=ns]. Therefore, all three baseline samples
were collapsed into a baseline average for continuous (1568.73 ± 65.93 fmol/min) and
discontinuous (1713.43 ± 151.32 fmol/min) walking for use in subsequent analyses comparing
baseline levels of extracellular DA against samples taken during walking.
A repeated measures two-way ANOVA was used to analyze the effects of treadmill
walking on 5-HIAA levels. No significant differences in extracellular 5-HIAA were found
between continuous vs. discontinuous treadmill walking [F(1,8)=0.322; p=ns]. A main effect
over time was found for 5-HIAA [F(3,24)=15.48; p<0.001]. Subsequent post-hoc analyses
revealed significant differences from baseline vs. 20-, 40- and 60-min (p<0.05). The interaction
between walking condition and repeated measures of 5-HIAA was not significant
[F(3,24)=0.258; p=ns].
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Figure 8. Extracellular DA levels during baseline and both treadmill walking conditions. There was a significant increase
in extracellular DA across all samples collected during treadmill walking compared to the mean (±SEM) of baseline
(p<0.05).
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Discussion
The major finding of this report is that significant increases in extracellular DA levels
related to treadmill walking can be measured using IVMCD. The initial hypothesis that a pattern
of striatal DA overflow could be related to initiation and termination of movement was not
supported. Specifically, it was predicted that greater DA utilization, reflected as increases in DA
from microdialysate samples, would be observed during discontinuous walking compared to
continuous walking. However, the present results found no significant difference in DA release
between continuous vs. discontinuous walking. This study is significant because it provides a
profile of neurochemical evidence that supports the idea that exocytotic mechanisms can be
detected using IVMCD without reliance upon pharmacological manipulations. Similar to DA, its
major metabolites DOPAC and HVA, and the serotonin metabolite 5-HIAA, increased during
treadmill walking from resting state levels. The concomitant increases in extracellular DA and its
metabolites suggest that IVMCD may be able to capture dynamic changes in presynaptic
mechanisms such as release and reuptake in response to behavioral activation. There is a
preponderance of evidence for a modulatory role of DA in movement and the reasons why such a
function was not observed are discussed. A clear understanding for the role of DA in movement
production is crucial for the development of biomedical interventions involving basal ganglia
disease.
Role of DA in movement initiation
In humans, problems with initiation of movement are a disabling motor deficit typically
seen in Parkinson’s disease. Deficits in initiation and termination of movement can particularly
be seen in gait disorders such as festination and freezing of gait. Surprisingly, these disabling
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gait disorders still remain poorly understood (Iansek et al., 2006). The idea that DA is important
for initiation of movement, however, is inconsistent throughout the literature.
If, in fact, the motor loop of the basal ganglia is important for initiation and termination
of movement, then the present data suggest that a more complex experimental design is required
to capture this function. The present findings are compelling that DA is involved in sustaining
movement rather than in initiation or termination of movement. However, the literature about the
functional nature of striatal DA in voluntary movement has been controversial for several
decades (DeLong, 1990; Middleton and Strick, 2000; Takakusaki et al., 2004; Grillner et al.,
2005; Aceves et al., 2011). Virtually all studies that have assessed this problem have done so by
depleting striatal DA in combination with a battery of sensory, motor and cognitive tests to
dissect the behaviors mediated by striatal DA neurons (Schallert & Hall, 1988; DeLong, 1990;
Damsma et al., 1992; Cousins & Salamone, 1996; Brasted et al., 1997; Bromberg-Martin et al.,
2010). In the unilateral 6-OHDA model, rats have been shown to display delayed initiation of
movement on the contralateral side of the lesion in conditioned circling behavior (Dunnett &
Bjorklund, 1983) in a bar-pressing paradigm (Cousins & Salamone, 1996), and in a nose-hole
poke choice response task (Brasted et al., 1997). In contrast, movement execution remains intact
once the behavior has been initiated. These movement initiation deficits are not simply due to
sensorimotor neglect. Spirduso et al. (1985) found that rats with much smaller (11-24%) striatal
DA lesions that spare sensorimotor ability still demonstrated movement initiation deficits in a
reactive capacity task which requires rapid initiation of high speed movements. Therefore,
dopamine seems likely to be important for initiation of movement.
Understanding the exact relationship between DA and movement remains a complex task
given that in contrast, a number of studies have found support for the competing hypothesis that
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DA is necessary for sustaining movement but not for initiating it (Döbrössy & Dunnet, 1997;
Brasted et al., 1998). During a lateralized choice reaction task, overall movement execution (total
time to respond) to a contralateral stimulus was increased but not reaction time (time to initiate
movement). Conversely, when looking at DA activity as a function of continuous locomotion not
every study finds significant increases in DA release as predicted if DA was critical for
movement execution (Castañeda et al., 1990; Damsma et al., 1992). Clearly, more work needs to
be done to understand the role of basal ganglia DA in mediating voluntary behavior. However,
the ability to delineate such a function is likely to be limited because the technology for
measuring DA and the kinematic analyses of behavior have not converged sufficiently to
illuminate these complex relationships.
A significant challenge in this line of investigation is the operational distinction between
initiation versus execution of movement. These concepts might be confounded by the use of
different behavioral tasks in different studies. For example, when rats are placed in two
conceptually similar reaction time tasks they display initiation deficits in a nose-poke paradigm
but execution deficits in a bar-pressing task following unilateral DA depletion (Brasted, et al.,
1998). These paradoxical results exemplify the contradictory evidence that mottles the literature
about the role of DA in initiation and execution of movement. The challenge in the study of
voluntary movement is that even within continuous locomotion there are smaller movement units
performed in a chain sequence that constitute the “continuous” gait pattern (Takakusaki, 2013;
Whishaw et al., 2010). Each of these units could be considered to have an initiation and
termination cycle, creating a problem when trying to define which unit constitutes initiation
versus execution of movement. To avoid the confounds created by complex behavioral actions,
such as respondent behavior reliant upon sensorimotor integration and reinforcement effects, the
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present study utilized a simple treadmill walking paradigm in a within-subjects experimental
design. The only difference in the motor behavior between the two experimental manipulations
was the repeated initiation and termination of treadmill walking in the discontinuous compared
to the continuous condition.
Studies have found support for both the ideas that DA is important for
initiating/terminating versus sustaining movement (Dunnett & Bjorklund, 1983; Döbrössy &
Dunnet, 1997; Brasted, et al., 1998). In the present study, if striatal DA was important only for
maintenance of locomotion then, lower DA levels would have been predicted during
discontinuous walking compared to continuous locomotion when comparisons were made
inclusive of the entire 60-min test period. In this way, the present data suggest striatal DA plays
an important function for sustaining locomotion. There was a consistent and similar increase in
extracellular DA levels during continuous versus discontinuous test phases. However, it is
important to consider that during discontinuous walking rats repeatedly engaged in initiation and
termination of movement unlike the sustained execution that took place during continuous
walking. In other words, during the discontinuous phase, rats walked for only two-thirds, or 40
min, the amount of time as in the continuous phase, which was 60 min. Quite significantly, when
differences in the absolute amount of time spent walking was adjusted in the measures of
extracellular DA, these results strongly suggest that repetitive initiation and termination of
locomotion produced significantly higher levels of DA overflow.
Therefore, viewed in this way, the corrected results support the hypothesis that DA is
important for initiation and termination of movement. The present study provide compelling
data, for the first time, that it will be important for future studies to design experiments that are
adequately elegant to dissociate these two components of locomotion, its initiation and
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termination compared to its sustained execution. In addition, it will be important to determine
how the present findings generalize to other basal ganglia-mediated behaviors other than
locomotion, especially as regards understanding the nature of behavioral decomposition during
motor disorders.
The Behavioral Function of the Basal Ganglia is Not Simple
A compelling observation from previous studies is that many impart a reward component
to evoke motor behavior. This poses a critical confound for testing the motor function of DA
given that positive reinforcement has been extensively shown to increase DA activity (Schultz,
1998; Berridge & Robinson, 1998; Wise, 2005). However, DA within the limbic reward system
has also been shown to be a system more complex than originally thought that has the capacity to
signal “reward prediction error” and not just reward-paired cues (Schultz et al., 1997). This
problem has been captured mainly by Dowd and Dunnett (2007) who have tried to understand
the interaction of motor (habit) and limbic (reward) behavior when interpreting motor deficits in
the 6-OHDA model. They propose that the movement deficits observed in the hemiparkinsonian
rat model are derived from the loss of the dopaminergic rewarding signal associated with the task
rather than deficits in motor abilities. The idea that DA is important for learning a motivated
behavior has been proposed repeatedly throughout the literature (see Bromberg-Martin et al.,
2010 for a review). Anatomical studies showing that the striatum is segregated into striosomes
and matrisomes also support the idea that DA integrates movement and reward (Johnston et al.,
1990). The striosomes receive inputs from limbic systems, while the matrisomes receive input
from motor and premotor cortex (Haber, 2003). Although the idea proposed by Dowd and
Dunnett (2007) that disruption of the dopaminergic rewarding signal is partially responsible for
the loss of conditioned response after a unilateral 6-OHDA lesion is a compelling hypothesis,
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other studies suggest otherwise. For example, using a mathematical model of operant
conditioning that accounts for motor capacity, motivation, and short term memory (Mathematical
Principles of Reinforcement; Killen, 1994), Avila et al. (2008) investigated the effects of 6hydroxydopamine-induced DA depletions on break point performance. These authors concluded
that a disruption in motor behavior, rather than upon motivation, played a significant role in
performance deficits.
The present study attempted to mitigate the influence of a reinforcement factor by
training animals to walk on a treadmill without a positive reinforcer (e.g., food reward). This
does not completely eliminate the possibility of a negative reinforcer such as the discomfort of
standing on a moving treadmill belt. However, negative reinforcers have been more frequently
associated with decreases in DA levels (Mark et al., 1991; Lui et al., 2008; Roitman et al., 2008)
rather than increases. How such a factor might influence the present results is not known.
An important aspect to consider about the experimental design of this study is whether
the integration of different sensory and motor systems needed to produce normal gait pattern and
modulate locomotion may mask any measurable changes in DA activation during initiation and
termination of treadmill walking. Locomotor behavior involves sequential activation of different
muscle groups needed for postural control (cortical and brain steam-derived pathways),
synchronization based on proprioceptive and kinesthetic feedback (somatosensory, cerebellum)
and intersegmental muscle coordination (spinal cord). Central pattern generators at brainstem
and spinal cord levels are likely to coordinate gait rhythm that does not require input from higher
motor systems and may decrease the need for basal ganglia modulation. It is beyond the scope
of the present project to speculate about this complex integration. However, the present study
does show a persistent increase of extracellular DA during treadmill walking. It is therefore
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reasonable to speculate that future studies can use treadmill walking in combination with
pharmacological manipulations targeting DA-modulating mechanisms to delve into the exact
role of DA in locomotion.
Reliable Methodology to Measure DA Release.
One concern in the present study is the relatively long collection period necessary to
collect microdialysate samples that limits temporal resolution by IVMCD. It is clear that a
subsecond grain of analysis will be useful to understand the moment-by-moment utilization of
DA needed to initiate movement in future studies. Future studies that examine the role of DA in
the initiation or execution of movement will have to consider modifications in procedural or
technical requirements. A possible solution to capture DA increase during initiation and
termination of movement using microdialysis is to increase the frequency at which rats start/stop
walking on the treadmill. A second alternative to consider for future studies is to use
chronoamperometry, which allows readings of DA activity in milliseconds and might provide a
more succinct profile of DA activity during initiation versus execution.
Despite the inconsistent literature reporting whether DA increases or not with continuous
locomotion, the present study has demonstrated a reliable method to evoke functional DA release
that does not rely on pharmacological agents. The significant contribution of the present study is
to communicate that physiologically, rather than pharmacologically, induced changes can be
observed with IVMCD. This method will serve as a tool to address DA-related questions in the
future.
This study was important to conduct because a substantial number of studies use
pharmacological

manipulations

to

stimulate

neurotransmitter

overflow.

However,

pharmacologically induced DA overflow usually depends on mechanisms different than those
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used for exocytosis. For example, amphetamine is a drug commonly used to produce DA
overflow. Unfortunately, the mechanism of action by which amphetamine causes DA overflow
involves reversing the function of the dopamine transporter (DAT), not exocytotic mechanisms
that involve depolarizing inputs that yield calcium-dependent release of DA from storage
vesicles. Interestingly, while amphetamine administration results in DA increase, the DA
metabolites decrease since DA cannot undergo reuptake into the cell where the majority of
neurotransmitter is degraded (Castañeda et al., 1990). In the present treadmill-walking study, the
DA metabolites DOPAC and HVA levels increased, supporting the idea that increases in DA
release should be followed by activation of downstream presynaptic mechanisms of reuptake and
enzymatic degradation. Therefore, analyzing patterns of DA activity during neurologically
relevant behavioral activity must include measures of DA metabolites to more fully understand
how presynaptic mechanisms govern exocytosis.
Finally, this study also reports that the levels of the serotonin metabolite 5-HIAA
significantly increased with treadmill walking. This finding supports the idea that DA as a lone
mediator may be too simple for control of the initiation and termination of movement. Future
studies may do well to expand the evaluation of other neurotransmitter systems within the basal
ganglia, including serotonin.
Overall, the present work was able to demonstrate a reliable and consistent increase in
functional DA release as a consequence of motor behavior without the potential confound
derived from introducing a reward component. This study establishes a novel finding for the
concurrent importance of DA in mediating initiation and termination, as well as sustained
execution of locomotor behavior. Utilizing this technique will also allow the examination of DA
activation in an exocytotic manner – rather than depending upon the prevalent use of drugs to
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pharmacologically stimulate DA “release”. For example, this technique will be useful to answer
future questions about functional changes in DA release in models of Parkinson’s disease and
drug addiction.
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